InSightec Receives $12.5M From Chinese Investors

September 15, 2014 | Elbit Imaging announced that it received a $12.5 million investment from a Chinese investment group. According to the company, the money is to be directed at Elbit Imaging’s company InSightec, a company treating cancer and other diseases using focused ultrasound therapy to destroy issue in a non-invasive procedure. The Chinese investment group includes Shanghai GEOC, Hengtong Investment Limited Partnership, and Fortune China. Elbit Imaging owns 37.6 percent of InSightec and recently the latter company received a $37.5 million investment from the York Fund, the largest shareholder in Elbit Imaging. Elbit Imaging founded Elbit Medical to allow its medical companies to be combined into a single company, InSightec and Gamida Cell.